Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced that the final…
Read More
Imagin Medical (CSE: IME) (OTCQB: IMEXF) has developed the i/Blue Imaging System(TM), an innovative technology designed to significantly improve the way surgeons visualize cancerous cells for more accurate bladder resection….
Vancouver, B.C. and Boston, MA, May 19, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress towards...
Read More
Prospective evaluation of blue-light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.
Lotan Y, Chaplin I, Ahmadi H, Meng X, Roberts S, Ladi-Seyedian S, Bagrodia A, Margulis V, Woldu S, Daneshmand S.
BJU Int. 2021 Jan;127(1):108-113. doi: 10.1111/bju.15166. Epub 2020 Aug 6.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f32648957%2f&c=E,1,p6aIPOJ9u0U9VIqE_AgiQqbDZFZ16wx5VmbjSt0KVPKiSOaFO89n6iLubYKOUZUOksfJJQaqDvKXlRLnY5iNv8f8Bjo30vf4cjuOPNdtK7jj&typo=1
VANCOUVER, British Columbia, and BOSTON, Jan. 13, 2021 -- via InvestorWire – Imagin Medical (CSE: IME) (OTC: IMEXF) (FRA: DPD2) (the “Company”) announces that critical milestones met in the second...
Read More
Vancouver, B.C. and Boston, MA, October 7, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it has selected...
Read More
- New Video, Podcast Episode Available on Imagin Medical’s Website - Vancouver, B.C. and Boston, MA, July 15, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol:...
Read More
Vancouver, B.C. and Boston, MA, May 21, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that its contract design...
Read More
Vancouver, B.C. and Boston, MA, March 10, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported ongoing market research feedback...
Read More
Vancouver, B.C. and Boston, MA, February 10, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that its President and...
Read More
